New Standard of Care for Metastatic Renal Cell Carcinoma New Standard of Care for Metastatic Renal Cell Carcinoma
Combination treatment with pembrolizumab and axitinib significantly improved survival outcomes as compared with sunitinib.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Health | Hematology | Kidney Cancer | Renal Cell Carcinoma